No Causal Effect of COVID-19 on Varicella-Zoster Infection, Herpes Zoster Progression, and Postherpetic Neuralgia: A Two-Sample Mendelian Randomization Study

References

• Kennedy PGE, Gershon AA. Clinical features of varicella-zoster virus infection. Viruses. 2018;10(11):609. doi:10.3390/v10110609
   PubMed Web of Science ®Google Scholar
• Freer G, Pistello M. Varicella-zoster virus infection: natural history, clinical manifestations, immunity and current and future vaccination strategies. New Microbiol. 2018;41(2):95–105.
   PubMed Web of Science ®Google Scholar
• Gershon AA, Breuer J, Cohen JI, et al. Varicella zoster virus infection. Nat Rev Dis Primers. 2015;1:15016. doi:10.1038/nrdp.2015.16
   PubMed Web of Science ®Google Scholar
• Bhavsar A, Lonnet G, Wang C, et al. Increased risk of herpes zoster in adults ≥50 years old diagnosed With COVID-19 in the United States. Open Forum Infect Dis. 2022;9(5):ofac118. doi:10.1093/ofid/ofac118
   PubMed Web of Science ®Google Scholar
• Algaadi SA. Herpes zoster and COVID-19 infection: a coincidence or a causal relationship? Infection. 2022;50(2):289–293. doi:10.1007/s15010-021-01714-6
   PubMed Web of Science ®Google Scholar
• Diez-Domingo J, Parikh R, Bhavsar AB, Cisneros E, McCormick N, Lecrenier N. Can COVID-19 increase the risk of herpes zoster? a narrative review. Dermatol Ther. 2021;11(4):1119–1126. doi:10.1007/s13555-021-00549-1
   Web of Science ®Google Scholar
• Davey Smith G, Hemani G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Genet. 2014;23(R1):R89–98. doi:10.1093/hmg/ddu328
   PubMed Web of Science ®Google Scholar
• Sanderson E, Smith GD, Windmeijer F, Bowden J. Corrigendum to: an examination of multivariable Mendelian randomization in the single-sample and two-sample summary data settings. Int J Epidemiol. 2020;49(3):1057. doi:10.1093/ije/dyaa101
   PubMed Web of Science ®Google Scholar
• Katz J, Yue S, Xue W. Herpes simplex and herpes zoster viruses in COVID-19 patients. Ir J Med Sci. 2022;191(3):1093–1097. doi:10.1007/s11845-021-02714-z
   PubMed Web of Science ®Google Scholar
• Elsaie ML, Nada HA. Herpes zoster (shingles) complicating the course of COVID19 infection. J DermatolTreat. 2022;33(2):1123–1125. doi:10.1080/09546634.2020.1782823
   Google Scholar
• Shors AR. Herpes zoster and severe acute herpetic neuralgia as a complication of COVID-19 infection. JAAD Case Rep. 2020;6(7):656–657. doi:10.1016/j.jdcr.2020.05.012
   PubMedGoogle Scholar
• Sil A, Bhanja DB, Sarkar AD, Chandra A. Herpes zoster involving trigeminal nerve: an early cutaneous predictor of COVID-19-a case series and review of the literature. J Cosmet Dermatol. 2022;21(4):1371–1373. doi:10.1111/jocd.14679
   PubMed Web of Science ®Google Scholar
• Tartari F, Spadotto A, Zengarini C, et al. Herpes zoster in COVID-19-positive patients. Int J Dermatol. 2020;59(8):1028–1029. doi:10.1111/ijd.15001
   PubMed Web of Science ®Google Scholar
• Narasimhan M, Ramakrishnan R, Durai PCT, Sneha B. Association between COVID-19 infection and herpes zoster: a case series. J Family Med Prim Care. 2023;12(10):2516–2519. doi:10.4103/jfmpc.jfmpc_2112_22
   PubMedGoogle Scholar
• Patil A, Goldust M, Wollina U. Herpes zoster: a review of clinical manifestations and management. Viruses. 2022;14(2):192. doi:10.3390/v14020192
   PubMed Web of Science ®Google Scholar
• Xu R, Zhou Y, Cai L, et al. Co-reactivation of the human herpesvirus alpha subfamily (herpes simplex virus-1 and varicella zoster virus) in a critically ill patient with COVID-19. Br J Dermatol. 2020;183(6):1145–1147. doi:10.1111/bjd.19484
   PubMed Web of Science ®Google Scholar
• Pona A, Jiwani RA, Afriyie F, Labbe J, Cook PP, Mao Y. Herpes zoster as a potential complication of coronavirus disease 2019. Dermatol Ther. 2020;33(6):e13930. doi:10.1111/dth.13930
   PubMed Web of Science ®Google Scholar
• Xu B, Fan CY, Wang AL, et al. Suppressed T cell-mediated immunity in patients with COVID-19: a clinical retrospective study in Wuhan, China. J Infect. 2020;81(1):e51–e60. doi:10.1016/j.jinf.2020.04.012
   PubMed Web of Science ®Google Scholar
• Xiao S, Luo D, Xiao Y. Survivors of COVID-19 are at high risk of posttraumatic stress disorder. Glob Health Res Policy. 2020;5:29. doi:10.1186/s41256-020-00155-2
   PubMedGoogle Scholar
• Morell A, Barandun S. Prophylactic and therapeutic use of immunoglobulin for intravenous administration in patients with secondary immunodeficiencies associated with malignancies. Pediatr Infect Dis J. 1988;7(5 Suppl):S87–91.
   PubMed Web of Science ®Google Scholar
• Laing KJ, Ouwendijk WJD, Koelle DM, Verjans G. Immunobiology of varicella-zoster virus infection. J Infect Dis. 2018;218(suppl_2):S68–S74. doi:10.1093/infdis/jiy403
   PubMedGoogle Scholar
• Arvin AM. Varicella-zoster virus. Clin Microbiol Rev. 1996;9(3):361–381. doi:10.1128/CMR.9.3.361
   PubMed Web of Science ®Google Scholar
• Liu J, Lin J, Cai L, et al. Immunogenicity of varicella zoster virus DNA vaccines encoding glycoprotein E and immediate early protein 63 in mice. Viruses. 2022;14(6):1214. doi:10.3390/v14061214
   PubMed Web of Science ®Google Scholar
• Iseki M, Yamamoto T, Ogawa Y, et al. Efficacy and safety of intravenous fosphenytoin for patients with acute herpes zoster-associated pain: a placebo-controlled randomized trial. J Dermatol. 2024;51(2):234–242. doi:10.1111/1346-8138.17054
   PubMed Web of Science ®Google Scholar
• Johnson RW. Zoster-associated pain: what is known, who is at risk and how can it be managed? Herpes. 2007;14(Suppl 2):30–34.
   PubMedGoogle Scholar
• Dworkin RH, Perkins FM, Nagasako EM. Prospects for the prevention of postherpetic neuralgia in herpes zoster patients. Clin J Pain. 2000;16(2 Suppl):S90–100. doi:10.1097/00002508-200006001-00016
   PubMed Web of Science ®Google Scholar
• Hope-Simpson RE. The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med. 1965;58(1):9–20.
   PubMedGoogle Scholar